Ovarian conservation at the time of hysterectomy for benign disease

Vani Dandolu, Enrique Hernandez, Enrique Hernández
Obstetrics & Gynecology · 2005 · vol. 106(5, Part 1) , pp. 1106 · doi:10.1097/01.aog.0000186052.78067.5a · PMID:16260536 · W2322586382
Other OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-23 ⓘ

The provided text contains only author affiliations and lacks an abstract or research findings, making it impossible to generate a summary of the study's results regarding ovarian conservation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Department of Obstetrics and Gynecology, Division of Urogynecology, Temple University Hospital, Philadelphia, Pennsylvania (Dandolu) Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Temple University Hospital, Philadelphia, Pennsylvania (Hernandez)

My notes (saved in your browser only)

MeSH descriptors

Cardiovascular Diseases Hysterectomy Osteoporosis Ovariectomy Bone Density Conservation Agents Bone Density Conservation Agents Cardiovascular Diseases Cardiovascular Diseases Decision Support Techniques Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Osteoporosis Osteoporosis Ovarian Neoplasms Ovarian Neoplasms Ovariectomy Uterine Diseases Uterine Diseases

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

References (5)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:24.829172+00:00
unpaywall
last seen: 2026-10-26T06:31:53.434635+00:00
License: CC0 · commercial use OK